SOURCE: The Traders Network Show - Clear Channel / iHeart Radio

The Traders Network Show - Clear Channel / iHeart Radio

October 15, 2014 07:28 ET

CEO Joseph Pandolfino of 22nd Century Group to Be Interviewed Live on Clear Channel Business Talk Radio -- October 16, 2014 -- 8am ET

Interview Airs at 8:00am EDT / 5:00am PDT / 7:00am CDT on "The Traders Network Radio Show," Hosted by Michael Yorba

DALLAS, TX--(Marketwired - Oct 15, 2014) - "The Traders Network Show" broadcasted daily on Clear Channel - iHeart Radio DFW1190AM KFXR, is pleased to announce 22nd Century Group, Inc. (NYSE MKT: XXII) CEO Joseph Pandolfino will be interviewed live on Thursday, Oct 16th at 8am EDT by host Michael Yorba streamed globally on iHeart Radio. 22nd Century Group is a leading plant biotechnology company focused on tobacco harm reduction products produced from modifying the nicotine content in tobacco plants and the development of novel, cannabis plant varieties -- all through genetic engineering and plant breeding.

In this exclusive two-segment interview, Mr. Pandolfino will talk about the company's proprietary technology that allows (i) the level of nicotine in the tobacco plant to be decreased or increased and (ii) the levels of cannabinoids to be decreased or increased in addition to the cannabinoid profile being tailored.

We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen via Clear Channel's nationally syndicated iHeart Radio stream.

Date: October 16, 2014 
Start Time:  8:00am EDT | 5:00am PDT | 7:00am CDT (U.S.)
Network: Clear Channel- iHeart Media
Station: DFW 1190AM
KFXR Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: www.iheart.com/live/4276/?autoplay=true

About Clear Channel: Clear Channel's Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. Please see: www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted "The Traders Network Show" broadcasted live daily on Clear Channel DFW 1190AM KFXR from 6am - 7:30am and 2pm - 3pm CT, Monday-Friday. Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It's a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more. Shift your thinking and join us as we deliver "tomorrow's ideas today" on Clear Channel's The Traders Network Show.

About 22nd Century Group: 22nd Century is a plant biotechnology company whose proprietary technology through genetic engineering and plant breeding allows (i) the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased and (ii) the levels of cannabinoids to be decreased or increased in addition to the cannabinoid profile being tailored. 22nd Century owns or is the exclusive licensee of 129 issued patents in 78 countries plus an additional 51 pending patent applications, and 22nd Century has co-exclusive rights to another 16 patent applications. Goodrich Tobacco Company, LLC, Botanical Genetics, LLC, and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century Group.

Goodrich Tobacco is focused on commercial tobacco products and potentially less harmful cigarettes.

Botanical Genetics is focused on novel, cannabis plant varieties and natural, safe and effective cannabis-based products for human health, well-being and nutrition, in addition to industrial products refined from cannabis.

Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

A 1800PublicRelations.com PR Event

Contact Information